Page last updated: 2024-09-04

butylscopolammonium bromide and Peritoneal Neoplasms

butylscopolammonium bromide has been researched along with Peritoneal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, S; Li, S; Peng, X; Wang, P; Zhang, G1
Amthauer, H; Buchmann, E; Felix, R; Hosten, N; Ricke, J; Rieger, J; Sehouli, J; Stroszczynski, C1

Trials

1 trial(s) available for butylscopolammonium bromide and Peritoneal Neoplasms

ArticleYear
Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer.
    World journal of surgical oncology, 2015, Feb-15, Volume: 13

    Topics: Butylscopolammonium Bromide; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Intestinal Obstruction; Liver Neoplasms; Middle Aged; Neoplasm Staging; Octreotide; Ovarian Neoplasms; Parasympatholytics; Peritoneal Neoplasms; Pleural Neoplasms; Prognosis; Prospective Studies; Severity of Illness Index

2015

Other Studies

1 other study(ies) available for butylscopolammonium bromide and Peritoneal Neoplasms

ArticleYear
[Fat-saturated, contrast-enhanced spin-echo sequences in the magnetic resonance tomographic diagnosis of peritoneal carcinosis].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1999, Volume: 171, Issue:6

    Topics: Adult; Aged; Butylscopolammonium Bromide; Carcinoma; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Muscarinic Antagonists; Peritoneal Neoplasms; Retrospective Studies; Tomography, X-Ray Computed

1999
chemdatabank.com